TAVI at Low Surgical Risk — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Yes — TAVI is recommended for patients aged ≥70 years with tricuspid AV stenosis and suitable anatomy, irrespective of surgical risk
The 2025 ESC/EACTS VHD Guidelines lowered the age threshold for TAVI from ≥75 to ≥70 years for patients with tricuspid aortic valve stenosis and suitable anatomy, irrespective of surgical risk (Class I, LOE A). This was based on accumulating evidence from the DEDICATE-DZHK6, NOTION-2, and Evolut Low Risk trials demonstrating non-inferiority of TAVI to SAVR in patients aged 70-75. For patients <70 years with low surgical risk, SAVR remains recommended. The Heart Team should consider lifetime management, durability, need for future procedures, and patient preference in the final decision.
Reference: ESC/EACTS (2025): Guidelines for the Management of Valvular Heart Disease